135 related articles for article (PubMed ID: 7387799)
21. Refinement and feasibility testing of a manual micro-method for protamine titration.
Newall F; Johnston L; Ignjatovic V; Summerhayes R; Monagle P
Int J Lab Hematol; 2009 Aug; 31(4):457-61. PubMed ID: 18371057
[TBL] [Abstract][Full Text] [Related]
22. Heparin assay and protamine titration.
Anido G; Freeman DJ
Am J Clin Pathol; 1981 Oct; 76(4):410-5. PubMed ID: 7293964
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of disposable heparin sensors. Blood heparin measurements during open heart surgery.
Yun JH; Lee LM; Wahr JA; Fu B; Meyerhoff ME; Yang VC
ASAIO J; 1995; 41(3):M661-4. PubMed ID: 8573887
[TBL] [Abstract][Full Text] [Related]
24. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
[TBL] [Abstract][Full Text] [Related]
25. [Studies on plasma hypercoagulability. 3. An improved method for plasma heparin determination based on metachromatic activity and its levels in human plasma].
Satake K
Naika Hokan; 1969 May; 16(5):173-81. PubMed ID: 5387636
[No Abstract] [Full Text] [Related]
26. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
[TBL] [Abstract][Full Text] [Related]
27. An international collaborative study establishing a reference preparation for Antithrombin III.
Kirkwood TB; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1980 Feb; 43(1):10-5. PubMed ID: 7404474
[TBL] [Abstract][Full Text] [Related]
28. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
29. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
30. [Determination of the amount of heparin in the blood by titration with protamine sulfate].
Kaluzhenko RK; Murchakova AF
Lab Delo; 1966; 7():392-3. PubMed ID: 4170776
[No Abstract] [Full Text] [Related]
31. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
[TBL] [Abstract][Full Text] [Related]
32. Heparin/heparan sulfate anticoagulant glycosaminoglycans in human plasma of healthy donors: preliminary study on a small group of recruits.
Cecchi F; Pacini S; Gulisano M; Macchi C; Catini C; Lova RM; Fuzzi G; Ruggiero M; Vannucchi S
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):349-54. PubMed ID: 18600081
[TBL] [Abstract][Full Text] [Related]
33. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
34. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
Jeske W; Fareed J
Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antithrombin III assays using biological and chromogenic substrates.
Philo RD; Gaffney PJ
Br J Haematol; 1982 Jan; 50(1):147-56. PubMed ID: 7055531
[TBL] [Abstract][Full Text] [Related]
36. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
37. Standard and method independent units for heparin anticoagulant activities.
Hemker HC; Béguin S
Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
[TBL] [Abstract][Full Text] [Related]
38. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
[TBL] [Abstract][Full Text] [Related]
39. Semimicro-titrimetric method for the determination of activity-concentration of heparin.
El Kheir AA; Ahmed AK; El Bardicy GZ; Amer MM
Arzneimittelforschung; 1977; 27(3):551-5. PubMed ID: 577419
[TBL] [Abstract][Full Text] [Related]
40. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
